Fighting Fake Medicines Sold Online Requires Commitment to Cautioning Patients
Falsified and substandard medicine harms patients, potentially causing disease progression, adverse events, and even death. When patients buy medicine from an illegal online pharmacy, these negative outcomes are definite possibilities. In today’s post-pandemic era, when consumers shop online for everything including medicine, it is critical for patients to understand the risks associated with illegal online […]
Read More ›NABP Supports Efforts to Improve Pharmacist Workplace Safety and Well-Being to Safeguard Patient Safety
The National Association of Boards of Pharmacy® (NABP®) has released a policy statement detailing its support of current efforts to improve pharmacist workplace safety and well-being. The issues of pharmacist workload, burnout, and well-being, and their effect on patient safety, have been considered for years, but the coronavirus disease 2019 pandemic has brought concerns related to […]
Read More ›Joint Statement of FSMB and NABP on Inappropriate Prescribing and Dispensing of Medications During the COVID-19 Pandemic
Recent news reports indicate that in response to the coronavirus pandemic, some physicians are inappropriately prescribing medications (including chloroquine, hydroxychloroquine, and azithromycin) to prevent or treat COVID-19 for themselves or their family members, and that some pharmacies and hospitals may be stockpiling these medications in anticipation of future demand. In the midst of a national […]
Read More ›U.S. Healthcare Licensing and Regulatory Organizations Issue Joint Statement on COVID-19 Pandemic
As the leading national organizations representing state and territorial health regulatory boards in the United States that regulate the practice of medicine, nursing, pharmacy, physical therapy, psychology, occupational therapy, and social work, we wish to express support for the many efforts being undertaken by our member boards and staff to enable health care providers and […]
Read More ›Statement on Prescription Drug Importation Proposals
Prescription Drug Importation is Not a Viable Solution to High Prescription Drug Costs Policymakers, rightfully so, have sought to lower prescription drug costs for ordinary Americans. Some of the proposals being considered would allow for importation of prescription drugs from other countries where they are currently being sold at cheaper prices. These proposals have ranged […]
Read More ›NCPO Statement on Combatting the Opioid Crisis
The National Conference of Pharmaceutical Organizations (NCPO) is a coalition of organizations and associations that represents the discovery, manufacture, and distribution of medications and practitioners that provide effective patient care. Collectively, our organizations represent over 300,000 individual pharmacy practitioners and pharmaceutical scientists, companies engaged in diverse aspects of healthcare delivery, and the nation’s pharmacy regulators […]
Read More ›Tri-Regulator Collaborative Release Position Statements Addressing Electronic Health Records, Practitioner Burnout
The Tri-Regulator Collaborative, the governing boards of the three organizations representing the state boards that license physicians, nurses, and pharmacists – the Federation of State Medical Boards (FSMB), National Association of Boards of Pharmacy (NABP), and National Council of State Boards of Nursing (NCSBN) – have drafted and approved two position statements that highlight the […]
Read More ›NABP Issues Policy Statement Supporting the Pharmacist’s Role in Increasing Access to Opioid Overdose Reversal Drug
As the opioid overdose epidemic continues to take hundreds of lives each week, the National Association of Boards of Pharmacy® (NABP®) has issued a policy statement promoting an active role for pharmacists in expanding access to the opioid overdose reversal drug, naloxone. Nearly 17,000 people died from an overdose involving an opioid analgesic in 2011, four […]
Read More ›NABP Shares .Pharmacy Information at Beyond the Dot 2014 Conference
NABP provided information about online pharmacy safety and rogue Internet drug sellers, including an overview of the .pharmacy gTLD program, at the Beyond the Dot 2014 conference held in Washington, DC, on February 19, 2014. NABP emphasized the public health threat posed by rogue sites that often sell dangerous counterfeit drugs, and the need to establish […]
Read More ›The Tri-Regulator Collaborative Position Statement on Practice Location for Consumer Protection
As the organizations representing the state and territorial licensing boards in the United States that regulate the practice of medicine, pharmacy and nursing, the Federation of State Medical Boards (FSMB), National Association of Boards of Pharmacy (NABP), and National Council of State Boards of Nursing (NCSBN) affirm that in a consumer protection model, health care […]
Read More ›